Dr. Graham Erwin @grahamerwin.bsky.social receives NIH New Innovator Award! www.bcm.edu/news/dr-grah... @bcmhouston.bsky.social @bcmgenetics.bsky.social #BCMCancerCenter
October 8, 2025 at 7:22 PM
Dr. Graham Erwin @grahamerwin.bsky.social receives NIH New Innovator Award! www.bcm.edu/news/dr-grah... @bcmhouston.bsky.social @bcmgenetics.bsky.social #BCMCancerCenter
During #LymphomaAwarenessMonth, learn about potential new treatments @bcmhouston.bsky.social #BCMCancerCenter blogs.bcm.edu/2024/01/19/f...
September 22, 2026 at 2:01 PM
During #LymphomaAwarenessMonth, learn about potential new treatments @bcmhouston.bsky.social #BCMCancerCenter blogs.bcm.edu/2024/01/19/f...
Interested in biological factors that drive #Metastasis in #Osteosarcoma? Check BB Gyau, TK Man et al's paper in
@mdpiopenaccess.bsky.social @bcmhouston.bsky.social #BCMCancerCenter www.mdpi.com/2072-6694/17... #cancer #research
@mdpiopenaccess.bsky.social @bcmhouston.bsky.social #BCMCancerCenter www.mdpi.com/2072-6694/17... #cancer #research
June 1, 2026 at 2:03 PM
Interested in biological factors that drive #Metastasis in #Osteosarcoma? Check BB Gyau, TK Man et al's paper in
@mdpiopenaccess.bsky.social @bcmhouston.bsky.social #BCMCancerCenter www.mdpi.com/2072-6694/17... #cancer #research
@mdpiopenaccess.bsky.social @bcmhouston.bsky.social #BCMCancerCenter www.mdpi.com/2072-6694/17... #cancer #research
It's #NationalPostdocAppreciationWeek! Meet Dr. H. Lin and learn about his postdoctoral experience and his evolution as a researcher as he ventured beyond his original training to solve unanticipated scientific questions. @bcmhouston.bsky.social #BCMCancerCenter blogs.bcm.edu/2026/09/22/n...
September 22, 2026 at 3:59 PM
It's #NationalPostdocAppreciationWeek! Meet Dr. H. Lin and learn about his postdoctoral experience and his evolution as a researcher as he ventured beyond his original training to solve unanticipated scientific questions. @bcmhouston.bsky.social #BCMCancerCenter blogs.bcm.edu/2026/09/22/n...
X. Zhang Lab, L Yu et al discovered different ways for #tripleNegativeBreastCancer to become #resistant to #therapy. @jci.org @bcmhouston.bsky.social #BCMCancerCenter www.bcm.edu/news/there-i...
There is more than one way for triple-negative breast cancer to become resistant to therapy
About 50% of triple-negative breast cancer (TNBC) patients develop resistance to therapy. When resistance arises, tumors are more likely to come back after...
www.bcm.edu
March 2, 2026 at 3:06 PM
X. Zhang Lab, L Yu et al discovered different ways for #tripleNegativeBreastCancer to become #resistant to #therapy. @jci.org @bcmhouston.bsky.social #BCMCancerCenter www.bcm.edu/news/there-i...
Check the @nature.com paper by @rosenberglabbcm.bsky.social on a new endogenous mechanism that promotes #DNA damage, #mutations. @bcmhouston.bsky.social @bcmgenetics.bsky.social #BCMCancerCenter
What RNA polymerase gets up to in the genome and how mutations happen! Just out in Nature! Many thanks to many collaborators & congrats 1st author Jingjing Liu! www.nature.com/articles/s41...
February 21, 2025 at 5:45 PM
Check the @nature.com paper by @rosenberglabbcm.bsky.social on a new endogenous mechanism that promotes #DNA damage, #mutations. @bcmhouston.bsky.social @bcmgenetics.bsky.social #BCMCancerCenter
What does a tissue microenvironment that favors #metastasis look like? X. Zhang Lab et al found an answer. @cp-cell.bsky.social @bcmhouston.bsky.social #cancer #BCMCancerCenter #breastCancer www.bcm.edu/news/new-met...
April 30, 2026 at 5:53 PM
What does a tissue microenvironment that favors #metastasis look like? X. Zhang Lab et al found an answer. @cp-cell.bsky.social @bcmhouston.bsky.social #cancer #BCMCancerCenter #breastCancer www.bcm.edu/news/new-met...
#CPRIT awards more than $15 million to BCM @bcmhouston.bsky.social for #CancerResearch #BCMCancerCenter www.bcm.edu/news/cprit-a...
CPRIT awards more than $15 million to BCM for cancer research
Researchers at the Dan L Duncan Comprehensive Cancer Center at Baylor College of Medicine have been awarded more than $15 million in grants by the Cancer...
www.bcm.edu
November 21, 2025 at 10:28 PM
#CPRIT awards more than $15 million to BCM @bcmhouston.bsky.social for #CancerResearch #BCMCancerCenter www.bcm.edu/news/cprit-a...
Congratulations, Dr. Pavan Reddy, who has been elected to the newest class of American Association for the Advancement of Science Fellows! @aaas.org @bcmhouston.bsky.social #BCMCancerCenter www.bcm.edu/news/dr-pava...
March 27, 2025 at 4:59 PM
Congratulations, Dr. Pavan Reddy, who has been elected to the newest class of American Association for the Advancement of Science Fellows! @aaas.org @bcmhouston.bsky.social #BCMCancerCenter www.bcm.edu/news/dr-pava...
#EstesLab_BCM et al have achieved a #breakthrough on #HumanNorovirus #research, accelerating viral, vaccine and treatment studies. #HumanIntestinalEnteroids #ScienceAdvances @science.org @bcmhouston.bsky.social @tmcddc.bsky.social #BCMCancerCenter #BCMGradSchool blogs.bcm.edu/2026/02/05/f...
Breakthrough in human norovirus research: scientists overcome major obstacle to grow and study the virus
Growing and maintaining norovirus strains in the lab allows researchers to advance studies of viral structure, antiviral drug screening and vaccine development.
blogs.bcm.edu
February 5, 2026 at 5:17 PM
#EstesLab_BCM et al have achieved a #breakthrough on #HumanNorovirus #research, accelerating viral, vaccine and treatment studies. #HumanIntestinalEnteroids #ScienceAdvances @science.org @bcmhouston.bsky.social @tmcddc.bsky.social #BCMCancerCenter #BCMGradSchool blogs.bcm.edu/2026/02/05/f...
Team at @bcmhouston.bsky.social, @stjuderesearch.bsky.social et al reveals driver of the third most common pediatric #brainTumor. #ependymoma B Deneen, @alishakardian.bsky.social S. Mack @bcmneurosurgery.bsky.social #BCMGradSchool #BCMCancerCenter #TexasChildrens www.bcm.edu/news/zr-fusi...
ZR fusion protein sways normal brain cell development toward cancer growth
A team of researchers at Baylor College of Medicine, St. Jude Children’s Research Hospital, Texas Children’s Hospital and collaborating institutions...
www.bcm.edu
March 26, 2026 at 5:20 PM
Team at @bcmhouston.bsky.social, @stjuderesearch.bsky.social et al reveals driver of the third most common pediatric #brainTumor. #ependymoma B Deneen, @alishakardian.bsky.social S. Mack @bcmneurosurgery.bsky.social #BCMGradSchool #BCMCancerCenter #TexasChildrens www.bcm.edu/news/zr-fusi...
Drs. Sang Jun Han, D. Lonard et al are building the case for #SRC3 as a promising #therapeuticTarget for next-generation #cancer #immunotherapy. #Oncoimmunology @tandfonline.bsky.social @bcmhouston.bsky.social #BCMCancerCenter #HotTumor #ColdTumor blogs.bcm.edu/2026/03/26/f...
Research advances toward more effective, long-lasting and side effect-free cancer treatments
The Baylor team is building the case for SRC-3 as a promising therapeutic target for next-generation cancer immunotherapy.
blogs.bcm.edu
March 26, 2026 at 5:29 PM
Drs. Sang Jun Han, D. Lonard et al are building the case for #SRC3 as a promising #therapeuticTarget for next-generation #cancer #immunotherapy. #Oncoimmunology @tandfonline.bsky.social @bcmhouston.bsky.social #BCMCancerCenter #HotTumor #ColdTumor blogs.bcm.edu/2026/03/26/f...
Interested in novel therapies for #TripleNegative #BreastCancer? Drs. D. Pedroza, J Rosen et al have promising new findings. #AntiCSF1R #Immunochemotherapy @natcomms.nature.com #BCMCancerCenter @bcmhouston.bsky.social www.nature.com/articles/s41...
Anti-CSF-1R therapy with combined immuno-chemotherapy coordinate an adaptive immune response to eliminate macrophage enriched triple negative breast cancers - Nature Communications
Metastatic triple negative breast cancer (mTNBC) has limited treatments options. Here, this group presents a combination of low-dose cyclophosphamide, anti-CSF1R, and anti-PD-1 therapies to boost immu...
www.nature.com
February 5, 2026 at 3:59 PM
Interested in novel therapies for #TripleNegative #BreastCancer? Drs. D. Pedroza, J Rosen et al have promising new findings. #AntiCSF1R #Immunochemotherapy @natcomms.nature.com #BCMCancerCenter @bcmhouston.bsky.social www.nature.com/articles/s41...
#Immunotherapy for #PancreaticCancer shows promise. blogs.bcm.edu/2019/07/23/f... #pancreaticCancerAwarenessMonth @bcmhouston.bsky.social #BCMCancerCenter
Immunotherapy for pancreatic cancer shows promise
Clinical trials with T-cell therapy for pancreatic cancer show clinical responses with no serious side effects.
blogs.bcm.edu
November 11, 2025 at 3:26 PM
Some #breastCancers provide clues indicating whether they are susceptible to #therapy, helping inform treatment decisions. E Chang et al. #ScienceTM @bcmhouston.bsky.social #BCMCancerCenter blogs.bcm.edu/2025/09/18/f...
Breast cancer clues hint at response to therapy in animal models
The findings bring us one step closer to improving ER+ breast cancer patients’ response to therapy.
blogs.bcm.edu
September 23, 2025 at 7:35 PM
Some #breastCancers provide clues indicating whether they are susceptible to #therapy, helping inform treatment decisions. E Chang et al. #ScienceTM @bcmhouston.bsky.social #BCMCancerCenter blogs.bcm.edu/2025/09/18/f...
Check out our image this month; take a closer look at #metastaticmedulloblastoma #MichaelTaylorLab @bcmhouston.bsky.social #TexasChildrens #BCMCancerCenter @bcmneurosurgery.bsky.social #brainTumor blogs.bcm.edu/2025/05/06/f...
Image of the Month: A closer look at metastatic medulloblastoma
The image captures metastatic medulloblastoma tumor cells (green) intertwined with blood vessels (magenta) in the leptomeninges of a mouse model of the human condition.
blogs.bcm.edu
May 6, 2025 at 4:22 PM
Check out our image this month; take a closer look at #metastaticmedulloblastoma #MichaelTaylorLab @bcmhouston.bsky.social #TexasChildrens #BCMCancerCenter @bcmneurosurgery.bsky.social #brainTumor blogs.bcm.edu/2025/05/06/f...
Dr. T Cooper, R-C Hu et al focused on #MyotonicDystrophyType1 #heart problems testing a novel approach to restore normal function. #DM1 @jclinical-invest.bsky.social @bcmhouston.bsky.social #BCMCancerCenter #BCMGradSchool #Therapy blogs.bcm.edu/2025/03/18/f...
Restoring heart function in Myotonic Dystrophy Type 1
The findings are relevant to current therapeutic approaches for DM1 that are based on increasing MBNL protein.
blogs.bcm.edu
March 18, 2025 at 5:20 PM
Dr. T Cooper, R-C Hu et al focused on #MyotonicDystrophyType1 #heart problems testing a novel approach to restore normal function. #DM1 @jclinical-invest.bsky.social @bcmhouston.bsky.social #BCMCancerCenter #BCMGradSchool #Therapy blogs.bcm.edu/2025/03/18/f...
Drs. S. Lerner, M Holt, Y Dou et al made strides toward a better understanding of what makes some #bladderCancers resistant to #chemotherapy. #bcm_urology @bcmhouston.bsky.social #BCMCancerCenter @cp-cellrepmed.bsky.social cell.com/cell-reports...
Proteogenomic characterization unveils biomarkers associated with chemoresistance in muscle-invasive bladder cancer
Holt et al. perform proteogenomic characterization of 46 pre- and 14 post-treatment
muscle-invasive bladder tumors. Multi-omics clustering separates chemotherapy-sensitive
and -resistant tumors. In-de...
cell.com
July 31, 2025 at 4:21 PM
Drs. S. Lerner, M Holt, Y Dou et al made strides toward a better understanding of what makes some #bladderCancers resistant to #chemotherapy. #bcm_urology @bcmhouston.bsky.social #BCMCancerCenter @cp-cellrepmed.bsky.social cell.com/cell-reports...
These findings have direct implications for the field of #cancer #immunology and #boneMarrowTransplantation. P. Reddy, A. Chinnaiyan, M. Cieslik et al #cancer #treatments. @bcmhouston.bsky.social #BCMCancerCenter @umich.edu #NatureImmunol blogs.bcm.edu/2026/03/31/f...
Unexpected cancer vulnerability points at potential novel treatments
A novel way the immune system attacks target cells reshapes long-held assumptions in immunology and shows direct implications for the field of cancer immunology and bone marrow transplantation.
blogs.bcm.edu
March 31, 2026 at 6:27 PM
These findings have direct implications for the field of #cancer #immunology and #boneMarrowTransplantation. P. Reddy, A. Chinnaiyan, M. Cieslik et al #cancer #treatments. @bcmhouston.bsky.social #BCMCancerCenter @umich.edu #NatureImmunol blogs.bcm.edu/2026/03/31/f...
Researchers JParchem, RKeuls, RParchem et al were in the right place at the right time and uncovered key #placental responses to #COVID19. #AJOG_thegray #maternalFetalBarrier @bcmhouston.bsky.social #BCMGradSchool #BCMCancerCenter #preeclampsia #McGovernMed blogs.bcm.edu/2025/04/29/f...
Being in the right place at the right time reveals key placental response to COVID-19
Comparing placental responses in COVID-19 and preeclampsia revealed similarities that may help explain the overlapping presentation of these clinical syndromes.
blogs.bcm.edu
May 1, 2025 at 8:58 PM
Researchers JParchem, RKeuls, RParchem et al were in the right place at the right time and uncovered key #placental responses to #COVID19. #AJOG_thegray #maternalFetalBarrier @bcmhouston.bsky.social #BCMGradSchool #BCMCancerCenter #preeclampsia #McGovernMed blogs.bcm.edu/2025/04/29/f...
Researchers at @bcmhouston.bsky.social have developed an #AI model that reveals how protein modifications link genetic #mutations to #disease. B Zhang, C Wang, B Wen, K Li et al. @natmethods.nature.com @bcmgenetics.bsky.social #BCMCancerCenter www.bcm.edu/news/ai-reve...
AI reveals how protein modifications link mutations to disease
Researchers at Baylor College of Medicine have developed an artificial intelligence (AI) model that reveals how protein modifications link genetic mutations...
www.bcm.edu
August 26, 2025 at 7:15 PM
Researchers at @bcmhouston.bsky.social have developed an #AI model that reveals how protein modifications link genetic #mutations to #disease. B Zhang, C Wang, B Wen, K Li et al. @natmethods.nature.com @bcmgenetics.bsky.social #BCMCancerCenter www.bcm.edu/news/ai-reve...
Brain “stars” hold the power to preserve #cognitiveFunction in model of #AlzheimersDisease. DJ Choi @uthealthhouston.bsky.social, B. Deneen @bcmhouston.bsky.social et al @bcmneurosurgery.bsky.social #BCMCancerCenter #TCHResearchNews @natneuro.nature.com #astrocytes www.bcm.edu/news/brain-s...
Brain “stars” hold the power to preserve cognitive function in model of Alzheimer’s disease
Researchers at Baylor College of Medicine have discovered a natural mechanism that clears existing amyloid plaques in the brains of mouse models of Alzheimer’s...
www.bcm.edu
November 21, 2025 at 4:59 PM
Brain “stars” hold the power to preserve #cognitiveFunction in model of #AlzheimersDisease. DJ Choi @uthealthhouston.bsky.social, B. Deneen @bcmhouston.bsky.social et al @bcmneurosurgery.bsky.social #BCMCancerCenter #TCHResearchNews @natneuro.nature.com #astrocytes www.bcm.edu/news/brain-s...
A mutant of #p53, the 'guardian of the #genome', opens new possibilities for future personalized #cancer treatment. WC Lin @bcmhouston.bsky.social #BCMCancerCenter @commsbio.nature.com blogs.bcm.edu/2025/11/11/f...
p53 mutant R273H opens new avenues for future personalized cancer treatment
This study highlights the importance of understanding the specific type of p53 mutation in each patient’s tumor, as it may influence both disease behavior and therapeutic strategies.
blogs.bcm.edu
November 11, 2025 at 5:22 PM
A mutant of #p53, the 'guardian of the #genome', opens new possibilities for future personalized #cancer treatment. WC Lin @bcmhouston.bsky.social #BCMCancerCenter @commsbio.nature.com blogs.bcm.edu/2025/11/11/f...
Drs. S Lerner, M Holt, Y Dou et al found markers in muscle-invasive #bladderCancer tumors that would help predict which patients were most likely to benefit from #chemotherapy. #bcm_urology @bcmhouston.bsky.social #BCMCancerCenter @cp-cellrepmed.bsky.social www.bcm.edu/news/underst...
Understanding what makes some bladder cancers resistant to chemotherapy
About one quarter of patients with muscle-invasive bladder cancer (MIBC) may be treated and derive a benefit with the current standard chemotherapy. To...
www.bcm.edu
August 1, 2025 at 4:46 PM
Drs. S Lerner, M Holt, Y Dou et al found markers in muscle-invasive #bladderCancer tumors that would help predict which patients were most likely to benefit from #chemotherapy. #bcm_urology @bcmhouston.bsky.social #BCMCancerCenter @cp-cellrepmed.bsky.social www.bcm.edu/news/underst...
Dr. X Zhang et al identified immune cell abnormalities that may serve as blood #biomarkers to determine whether patients with #tripleNegativeBreastCancer will respond to therapy. @bcmhouston.bsky.social #BCRFcure #BCMCancerCenter @naturecellbiology.bsky.social www.bcrf.org/blog/zhang-s...
BCRF Research Identifies Immune Cell Changes in Triple-Negative Breast Cancers | Breast Cancer Research Foundation
BCRF investigator Dr. Xiang Zhang and his team identified two immune cell abnormalities that may serve as blood biomarkers for triple-negative breast cancer.
www.bcrf.org
March 25, 2025 at 7:56 PM
Dr. X Zhang et al identified immune cell abnormalities that may serve as blood #biomarkers to determine whether patients with #tripleNegativeBreastCancer will respond to therapy. @bcmhouston.bsky.social #BCRFcure #BCMCancerCenter @naturecellbiology.bsky.social www.bcrf.org/blog/zhang-s...